Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2018	Mar. 01, 2019	Jun. 29, 2018
Document Information [Line Items]
Entity Registrant Name	LIQUIDMETAL TECHNOLOGIES INC
Entity Central Index Key	0001141240
Trading Symbol	lqmt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding (in shares)		914,316,624
Entity Public Float			$ 126,921,923
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Shell Company	false

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 35,229	$ 41,309
Restricted cash	5	5
Trade accounts receivable, net of allowance for doubtful accounts	120	157
Inventory	31	391
Prepaid expenses and other current assets	363	326
Total current assets	35,748	42,188
Property and equipment, net	11,767	12,465
Patents and trademarks, net	322	408
Other assets	14	14
Total assets	47,851	55,075
Current liabilities:
Short-term debt
Accounts payable	253	92
Accrued liabilities	270	365
Deferred revenue	31	7
Total current liabilities	554	464
Long-term liabilities
Other long-term liabilities	856	856
Total liabilities	2,335	3,512
Shareholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2018 and December 31, 2017, respective
Common stock, $0.001 par value; 1,100,000,000 shares authorized; 914,206,832 and 908,768,116 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively	914	909
Warrants	18,179	18,179
Additional paid-in capital	279,306	277,924
Accumulated deficit	(252,809)	(245,376)
Non-controlling interest in subsidiary	(74)	(73)
Total shareholders' equity	45,516	51,563
Total liabilities and shareholders' equity	47,851	55,075
Warrant [Member]
Current liabilities:
Included in current liabilities
Long-term liabilities
Warrant liabilities, long-term	925	2,192
Call Option [Member]
Current liabilities:
Included in current liabilities

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,100,000,000	1,100,000,000
Common stock, shares issued (in shares)	914,206,832	908,768,116
Common stock, shares outstanding (in shares)	914,206,832	908,768,116

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenue
Revenues	$ 532,000	$ 321,000	$ 480,000
Cost of sales	1,164,000	696,000	553,000
Gross loss	(632,000)	(375,000)	(73,000)
Operating expenses
Selling, marketing, general and administrative	5,899,000	6,265,000	7,472,000
Research and development	2,429,000	1,962,000	2,342,000
Total operating expenses	8,328,000	8,227,000	9,814,000
Operating loss	(8,960,000)	(8,602,000)	(9,887,000)
Change in value of warrants, gain (loss)	1,267,000	(143,000)	(4,117,000)
Change in value of option liabilities, loss			(2,613,000)
Loss on contract modification			(2,126,000)
Interest expense			(9,000)
Interest income	259,000	55,000
Loss before income taxes	(7,434,000)	(8,690,000)	(18,752,000)
Income taxes
Net loss and comprehensive loss	(7,434,000)	(8,690,000)	(18,752,000)
Net loss attributable to non-controlling interest	1,000	3,000	8,000
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	$ (7,433,000)	$ (8,687,000)	$ (18,744,000)
Per common share basic and diluted:
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic (in dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)
Net loss per common share attributable to Liquidmetal Technologies shareholders, diluted (in dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)
Number of weighted average shares - basic (in shares)	910,546,059	897,273,890	640,157,919
Number of weighted average shares - diluted (in shares)	910,546,059	897,273,890	640,157,919
Product [Member]
Revenue
Revenues	$ 484,000	$ 255,000	$ 453,000
License [Member]
Revenue
Revenues	$ 48,000	$ 66,000	$ 27,000

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Warrant [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2015	0	477,149,485
Balance at Dec. 31, 2015		$ 477	$ 18,179	$ 203,735	$ (217,945)	$ (62)	$ 4,384
Common stock issuance, net of issuance costs (in shares)		405,000,000
Common stock issuance, net of issuance costs		$ 405		60,974			61,379
Stock option exercises (in shares)	0	2,197,199
Stock option exercises		$ 2		204			206
Stock-based compensation				1,694			1,694
Written call options				3,124			3,124
Loss on contract modification				2,126			2,126
Warrant exercises (in shares)		1,743,480
Warrant exercises		$ 2		663			665
Net loss					(18,744)	(8)	(18,752)
Balance (in shares) at Dec. 31, 2016	0	886,090,164
Balance at Dec. 31, 2016		$ 886	18,179	272,520	(236,689)	(70)	$ 54,826
Stock option exercises (in shares)		10,978,664					10,978,664
Stock option exercises		$ 11		1,227			$ 1,238
Stock-based compensation				1,255			1,255
Warrant exercises (in shares)		11,699,288
Warrant exercises		$ 12		2,922			2,934
Net loss					(8,687)	(3)	(8,690)
Balance (in shares) at Dec. 31, 2017	0	908,768,116
Balance at Dec. 31, 2017		$ 909	18,179	277,924	(245,376)	(73)	$ 51,563
Stock option exercises (in shares)		5,438,716					5,438,716
Stock option exercises		$ 5		458			$ 463
Stock-based compensation				924			924
Net loss					(7,433)	(1)	(7,434)
Balance (in shares) at Dec. 31, 2018	0	914,206,832
Balance at Dec. 31, 2018		$ 914	$ 18,179	$ 279,306	$ (252,809)	$ (74)	$ 45,516

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating activities:
Net loss	$ (7,434,000)	$ (8,690,000)	$ (18,752,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,078,000	634,000	527,000
Stock-based compensation	924,000	1,255,000	1,694,000
Loss on contract modification			2,126,000
Loss (gain) from change in value of warrants	(1,267,000)	143,000	4,117,000
Loss from change in value of option liabilities			2,613,000
Changes in operating assets and liabilities:
Trade accounts receivable	37,000	(62,000)	(65,000)
Inventory	360,000	(1,000)	(307,000)
Prepaid expenses and other current assets	(37,000)	(14,000)	96,000
Other assets		22,000	(5,000)
Accounts payable and accrued liabilities	64,000	(944,000)	204,000
Deferred revenue	24,000	(6,000)	(64,000)
Net cash used in operating activities	(6,251,000)	(7,663,000)	(7,816,000)
Investing Activities:
Purchases of property and equipment	(292,000)	(11,874,000)	(198,000)
Investment in patents and trademarks			(22,000)
Net cash used in investing activities	(292,000)	(11,874,000)	(220,000)
Financing Activities:
Repayment of short-term debt			(700,000)
Proceeds from exercise of stock options	463,000	1,238,000	206,000
Proceeds from exercise of warrants		712,000
Proceeds from stock issuance, net of issuance costs			62,650,000
Net cash provided by financing activities	463,000	1,950,000	62,156,000
Net increase (decrease) in cash, cash equivalents, and restricted cash	(6,080,000)	(17,587,000)	54,120,000
Cash, cash equivalents, and restricted cash at beginning of period	41,314,000	58,901,000	4,781,000
Cash, cash equivalents, and restricted cash at end of period	35,234,000	41,314,000	58,901,000
Supplemental Schedule of Non-Cash Financing Activities:
Cashless exercise of warrants		2,222,000	665,000
Accrued capital expenditures	$ 2,000

Note 1 - Description of Business	12 Months Ended
Note 1 - Description of Business	Dec. 31, 2018
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	1 . Description of Business Liquidmetal Technologies, Inc. (the “Company”) is a materials technology and manufacturing company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops, manufactures and sells products and custom parts from bulk amorphous alloys to customers in a wide range of industries. The Company also partners with third -party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. The Company’s alloys and the molding technologies it employs results in components that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials. The Company’s revenues are derived from i) selling bulk Liquidmetal alloy products to customers who produce medical devices, automotive assemblies, sports and leisure goods, and non-consumer electronic devices, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development, iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

Note 2 - Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Basis of Presentation and Significant Accounting Policies [Text Block]

. Summary of Significant Accounting Policies

Principles of Consolidation.

The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc., its special-purpose wholly-owned subsidiary, Crucible Intellectual Property LLC,

20321

Valencia LLC, and Liquidmetal Golf. All intercompany balances and transactions have been eliminated.

Non-

ontrolling

nterest.

The results of operations attributable to the non-controlling interest of Liquidmetal Golf are presented within equity and are shown separately from the Company’s equity.

Revenue Recognition

. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic

606

(“ASC

605”

), Revenue from Contracts with Customers. ASC

606

summarizes certain points in applying generally accepted accounting principles to revenue recognition in financial statements and provides guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry.

The Company’s revenue recognition policy complies with the requirements of ASC

606.

As a majority of the Company’s sales revenue continues to be recognized when products are shipped from its manufacturing facility, and there was

change in the recognition model historically applied to active license and royalty contracts under the new revenue standard, there was

adjustment to the opening balance of retained earnings. The impact to the Company’s results of operations is

not

material, on an on-going basis, because the analysis of the Company’s contracts under the new revenue standard supports a recognition model consistent with the Company’s previous revenue recognition model. Revenue on the majority of the Company’s contracts will continue to be recognized over time because of the continuous transfer of control to the customer.

Products

. Product revenues are primarily generated from the sale and prototyping of molds and bulk alloy products. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. When the Company receives consideration, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a sales contract, it records deferred revenue, which represents a contract liability. The Company will recognize deferred revenue as products revenue after it has transferred control of the goods or services to the customer and all revenue recognition criteria are met. Such amounts are

not

expected to be material on an ongoing basis.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

Licensing and royalties

. License revenue arrangements in general provide for the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted

may

be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time. Licensing revenues that are

one

-time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has

further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Practical Expedients and Exemptions

. The Company generally expenses sales commissions when incurred because the amortization period would have been

one

year or less. These costs are recorded within selling, marketing, general and administrative expenses. The Company does

not

disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of

one

year or less and (ii) contracts for which the Company recognizes revenue at the amount for which it has the right to invoice for services performed.

Cash

and cash equivalents

The Company considers all highly liquid investments with maturity dates of

three

months or less when purchased to be cash equivalents. The Company limits the amount of credit exposure to each individual financial institution and places its temporary cash into investments of high credit quality with a financial institution that exceeds federally insured limits. The Company has

not

experienced any losses related to these balances and believes its credit risk to be minimal. As of

December 31, 2018

and

2017,

the Company held deposits of

$15,187

and

respectively, in such highly liquid investments.

Trade Accounts Receivable.

The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of

December 31, 2018,

three

customers represented

90%,

$108,

of the total outstanding trade accounts receivable. As of

December 31, 2017,

three

customers represented

84%,

$131,

of the total outstanding trade accounts receivable. During

2018,

there were

three

major customers, who together accounted for

66%

of total revenue. During

2017,

there were

five

major customers, who together accounted for

63%

of total revenue. During

2016,

there were

three

major customers, who together accounted for

73%

of total revenue. In the future, the Company expects that a significant portion of the revenue

may

continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.

The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the consolidated statements of operations and comprehensive loss. At

December 31, 2018

and

2017,

the Company had

not

recorded an allowance for doubtful accounts.

Inventory.

Inventory is stated at the lower of weighted-average cost or net realizable value. Inventory is recorded at actual cost when purchased and then expensed at weighted-average cost as used in production and/or shipped to satisfy customer orders. We perform an analysis of our inventory balances at least quarterly to determine if the carrying amount of inventories exceeds their net realizable value. The analysis of estimated net realizable value is based on customer orders, market trends and historical pricing. If the carrying amount exceeds the estimated net realizable value, the carrying amount is reduced to the estimated net realizable value.

Property and Equipment.

Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from

one

five

years.

Intangible Assets.

Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to register and maintain patents and trademarks. Intangible assets are reported at cost, net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from

ten

seventeen

years.

Impairment of Long-lived Assets

. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset

may

be impaired. These evaluations

may

result from significant decreases in the overall market outlook for the Company’s technology or the market price of an asset, a significant adverse change in the extent or manner in which an asset is being used in its physical condition, a significant adverse change in legal factors or in the business climate that could affect the value of an asset, as well as economic or operational analyses. An impairment loss is recognized when the estimated fair value of the assets is less than the carrying value of the assets. Based on the Company’s review of both qualitative and quantitative factors

impairment charges have been recognized during the years ended

December 31, 2018,

2017,

and

2016,

respectively.

Fair Value

Measurements.

The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and restricted cash approximate their carrying value due to their short maturities and are classified as Level

instruments within the fair value hierarchy.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level

—

Quoted prices in active markets for identical assets or liabilities;

Level

—

Observable inputs other than Level

prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are

not

active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level

—

Unobservable inputs that are supported by little or

market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level

measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic

480

10,

FASB ASC Paragraph

815

and FASB ASC Subparagraph

815

addressing the accounting for certain financial instruments with characteristics of both liabilities and equity and derivative accounting. The fair value of such instruments is estimated using the Black-Scholes option pricing model. Due to the presence of certain anti-dilution and exercise price reset provisions, such instruments are required to be classified as liabilities (see notes

and

As of

December 31, 2018,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		-		-		-		-
Warrant liabilities (long-term)		925		-		925		-

As of

December 31, 2017,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		-		-		-		-
Warrant liabilities (long-term)		2,192		-		2,192		-

Research and Development Expenses.

Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred.

Advertising and Promotion Expenses.

Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were

$125,

$154

and

$83,

for the years ended

December 31, 2018,

2017

and

2016,

respectively.

Legal Costs.

Legal costs are expensed as incurred.

Stock-Based Compensation

. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic

718,

Share-based Payment

, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values. The fair value of stock options is calculated by using the Black-Scholes option pricing formula that requires estimates for expected volatility, expected dividends, the risk-free interest rate and the term of the option. If any of the assumptions used in the Black-Scholes model change significantly, share-based compensation expense

may

differ materially in the future from that recorded in the current period.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

Income Taxes.

Income taxes are provided under the asset and liability method as required by FASB ASC Topic

740,

Accounting for Income Taxes

. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. The effect of a tax rate change on deferred taxes is recognized in operations in the period that the change in the rate is enacted. Valuation allowances are established when necessary to reduce net deferred tax assets to the amount expected to be realized. Under the provisions of FASB ASC Topic

740,

the Company had

material unrecognized tax positions and

adjustments to liabilities or operations were required. The Company, when applicable, will recognize interest and penalties related to uncertain tax positions in income tax expense. There was

expense related to interest and penalties for the years ended

December 31, 2018,

2017

and

2016,

respectively.

Earnings Per Share.

Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Use of Estimates.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt, warrant valuations, and inventory valuation.

Subsequent Events.

The Company evaluated subsequent events through the filing of its Annual Report on Form

-K with the SEC.

Supplemental Cash Flow Information.

Cash payments for interest were

$0,

and

in the years ended

December 31, 2018,

2017,

and

2016,

respectively.

Recent Accounting Pronouncements.

Leases

February 2016,

the FASB issued an accounting standards update which modifies the accounting for leasing arrangements, particularly those arrangements classified as operating leases. This update will require entities to recognize the assets and liabilities arising from operating leases on the balance sheet. This guidance is effective for fiscal and interim periods beginning after

December 15, 2018

and is required to be applied retrospectively to all leasing arrangements. The adoption of this guidance is

not

expected to have a significant impact on the Company’s consolidated financial statements.

Liability Classified Warrants

July 2017,

the FASB issued an accounting standards update which modifies the requirements for the classification of certain financial instruments with down round features as equity versus liabilities. The guidance will allow for financial instruments, previously required to be presented as liabilities due to the presence of down round features, to be presented as equity upon meeting other criteria. This guidance is effective for fiscal and interim periods beginning after

December 15, 2018

and is required to be applied retrospectively to all financial instruments with down round features. The requirements applicable to the revised standard will be adopted using the full retrospective method during the

first

quarter of the year ending

December 31, 2019.

The Company expects the adoption of this guidance will have a significant impact on the consolidated balance sheet and statement of operations, particularly allocations between long term liabilities and the components of shareholders equity.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did

not

or are

not

believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 3 - Significant Transactions	12 Months Ended
Note 3 - Significant Transactions	Dec. 31, 2018
Notes to Financial Statements
Significant Transactions [Text Block]	3 . Significant Transactions Manufacturing Facility Purchase On February 16, 2017, the Company purchased a 41,000 square foot manufacturing facility located in Lake Forest, CA, where operations commenced during July 2017. The purchase price for the property was $7,818. LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) 2016 Purchase Agreement On March 10, 2016, the Company entered into a Securities Purchase Agreement (the “2016 Purchase Agreement”) with Liquidmetal Technology Limited, a Hong Kong company (the “Investor”), which is 100% owned by the Company’s Chairman and CEO, Professor Lugee Li (“Professor Li’). The 2016 Purchase Agreement provided for the purchase by the Investor of a total of 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. The transaction occurred in multiple closings, with the Investor having purchased 105,000,000 shares at a purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016 and the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 on October 26, 2016. In addition to the shares issuable under the 2016 Purchase Agreement, the Company issued to the Investor a warrant to acquire 10,066,809 shares of common stock (of which 2,609,913 of the warrant shares vested on March 10, 2016 and the remaining 7,456,896 warrant shares vested on October 26, 2016 at an exercise price of $0.07 per share). The warrant will expire on the tenth anniversary of its issuance date. Further, the 2016 Purchase Agreement provided that the Investor would have the right to designate three members of the Company’s board of directors, with one such member serving as Chairman. The 2016 Purchase Agreement also provided that, with certain limited exceptions, if the Company issues any shares of common stock at any time through the fifth anniversary of the 2016 Purchase Agreement, the Investor will have a preemptive right to subscribe for and to purchase at the same price per share (or at market price, in the case of issuance of shares pursuant to stock options) the number of shares necessary to maintain its ownership percentage of Company-issued shares of common stock. Eontec License Agreement On March 10, 2016, in connection with the 2016 Purchase Agreement, the Company and DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec agreed to cross-license their respective technologies. The Company’s Chairman and CEO, Professor Li, is also a major shareholder and Chairman of Eontec. The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, the Company granted to Eontec a paid-up, royalty-free, perpetual license to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of North America and Europe. In turn, Eontec granted to the Company a paid-up, royalty-free, perpetual license to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion of the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, Philippines, Singapore, South Korea, Thailand and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories. Beyond the License Agreement, the Company collaborates with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not limited to developing technologies to reduce the cost of amorphous alloys, working on die cast machine technology platforms to pursue broader markets, sharing knowledge to broaden our intellectual property portfolio, and utilizing Eontec’s volume production capabilities as a third party contract manufacturer. During March 2017, the Company signed contracts with Eontec to purchase two hot-crucible amorphous metal molding machines (“Machines”) at a total purchase price of $780. The Machines were delivered to the Company’s new manufacturing facility located in Lake Forest, CA in April 2017 and were operational during the fourth quarter of 2017. 201 4 Purchase Agreement On August 20, 2014, the Company entered into a common stock purchase agreement ( “2014 Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital would be committed to purchase up to an aggregate of $30,000 worth of the Company’s common stock, $0.001 par value, over the 36 -month term of the 2014 Purchase Agreement. On March 9, 2016, the Company terminated the 2014 Purchase Agreement. As of the date of termination, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share. Line of Credit Facility In February 2015, the Company entered into a $2,000 line of credit facility, with a fixed interest rate of 2.1%, which originally matured on February 13, 2016. The facility was extended through August 25, 2016, with reductions in available borrowings and associated collateral requirements to $1,000. On August 26, 2016, the Company fully repaid all outstanding principal and accrued interest balances due under the facility. As of such date, all collateral to the facility was released. Interest expense applicable to these borrowings was $0 for the year ended December 31, 2018, $0 for the year ended December 31, 2017, and $9 for the year ended December 31, 2016. LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) 2013 Stock Purchase Agreement On November 8, 2013, the Company entered into a Common Stock Purchase Agreement (the “2013 Purchase Agreement”) with certain investors that provided that the investors would purchase up to $20,000 worth of the Company’s common stock over a 36 -month term. In consideration for the execution and delivery of the 2013 Purchase Agreement, on November 8, 2013, the Company issued 2,666,667 shares of common stock to the investors. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014. As of the date of termination, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. July 2012 Private Placement On July 2, 2012, the Company entered into a private placement transaction (the “July 2012 Private Placement”) pursuant to which the Company issued $12,000 in principal amount of senior convertible notes that were due on September 1, 2013. The notes were convertible into shares of the Company’s common stock at a conversion price of $0.352 per share. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012. As of July 17, 2013, the Company had issued 163,641,547 shares of common stock in full satisfaction of the notes (see note 14 ). As a part of the July 2012 Private Placement, the Company issued warrants to purchase 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share (reduced to $0.17 per share under the anti-dilution and price reset provisions of the warrants). (see note 11 ). Apple License Transaction On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction. Visser Precision Cast, LLC License Agreement On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. On May 20, 2014, the Company and Visser entered into a settlement agreement significantly amending the Visser MTA, whereby the Company granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 ( the “Effective Date”). Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement. In addition, the settlement amended and restated the two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. The amended and restated warrant agreement includes the effect of anti-dilution adjustments and is exercisable for 21,317,094 shares at an exercise price of $0.16 per share under the anti-dilution provisions of the warrants (see Note 11 ). Other License Transactions On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel. On December 6, 2013, the companies entered into an Exclusivity Agreement for a 10 year term whereby the Company agreed, with certain exceptions and limitations, that the Company and its licensees would purchase amorphous alloy injection molding machines exclusively from Engel in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines. LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club parts and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf. In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”). Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches, but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Note 4 - Trade Accounts Receivable

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

. Trade accounts receivable

Trade accounts receivable were comprised of the following:

	December 31,
	2018		2017
Trade accounts receivable	$	120	$	157
Less: Allowance for doubtful accounts		-		-
Trade accounts receivable	$	120	$	157

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

Note 6 - Inventory

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Inventory Disclosure [Text Block]

. Inventory

Inventory totaled

$31

and

$391

as of

December 31, 2018

and

December 31, 2017,

respectively. Included within these totals are the following:

	December 31,
	2018		2017

Raw materials	$	-	$	367
Work in progress		31		24
Total		31		391

During the

third

quarter of

2018

and

fourth

quarter of

2017,

the Company recorded write-downs to raw materials inventory of

$642

and

$279,

respectively, with a corresponding increase to cost of sales. The write-downs were recorded in response to market conditions regarding part pricing for the Company’s technology and the overall view of the platform and materials that will be used to fulfill future prototyping and production contracts. Given market entry challenges for a new technology, and continued pressure to be price competitive with existing solutions, the Company cannot objectively predict the timing of volume production, the materials that will support such production, nor if such production can be fulfilled at a profit. While the Company continues to expect that volume production is achievable, and with viable economics, the lack of a current sales backlog and the Company’s lack of sales history does

not

support any future value with respect to on-hand raw materials as of

December 31, 2018.

Note 7 - Property and Equipment

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

Property and

Equipment

Property and equipment consist of the following:

	December 31,
	2018			2017

Land, building, and improvements	$	9,039		$	8,947
Machinery and equipment		5,745		$	5,577
Computer equipment		282			253
Office equipment, furnishings, and improvements		181			181
Total		15,247			14,958
Accumulated depreciation		(3,480	)		(2,493	)
Total property and equipment, net	$	11,767		$	12,465

Depreciation expense for the years ended

December 31, 2018,

2017

and

2016

was

$992,

$548,

and

$429,

respectively. For the year ended

December 31, 2018,

$76

of depreciation expense was included in cost of sales and

$916

was included in selling, marketing, general and administrative expenses. For the year ended

December 31, 2017,

$42

of depreciation expense was included in cost of sales and

$506

was included in selling, marketing, general and administrative expenses. For the year ended

December 31, 2016,

$20

of depreciation expense was included in cost of sales and

$409

was included in selling, marketing, general and administrative expenses.

February 16, 2017,

the Company purchased a

41,000

square foot building located at

20321

Valencia Circle, Lake Forest, California

92630.

July 2017,

the Company commenced use of the facility, primarily for manufacturing and office space. The total purchase price for the property was

$7,818,

exclusive of closing costs. The Company has funded the purchase through available cash on hand.

During

March 2017,

the Company signed contracts with Eontec to purchase

two

hot-crucible amorphous metal molding machines at a total purchase price of

$780.

The machines were delivered to the Company’s new manufacturing facility in

April 2017

and were operational during the

fourth

quarter of

2017.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

Note 8 - Patents and Trademarks, Net

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

Patents and trademarks, net

Patents and trademarks consist of the following:

	December 31,
	2018			2017

Purchased and licensed patent rights	$	566		$	566
Internally developed patents		1,686			1,686
Trademarks		148			148
Total		2,400			2,400
Accumulated amortization	$	(2,078	)	$	(1,992	)
Total intangible assets, net	$	322		$	408

Amortization expense was

$86,

and

$98

for the years ended

December 31, 2018,

2017,

and

2016,

respectively, and is included in research and development expense in the consolidated statements of operations and comprehensive loss. The estimated aggregate amortization expense for each of the

five

succeeding years is as follows:

December 31,	Aggregate Amortization Expense

2019	$	84
2020		81
2021		56
2022		29
2023		20
Thereafter		52
	$	322

Accumulated amortization for the years ended

December 31, 2018

and

2017

is as follows:

	December 31,
	2018			2017

Purchased and licensed patent rights	$	(548	)	$	(541	)
Internally developed patents		(1,400	)		(1,326	)
Trademarks		(130	)		(125	)
Total	$	(2,078	)	$	(1,992	)

The weighted average amortization periods for the years ended

December 31, 2018

and

2017

are as follows:

	December 31,
	2018		2017

Purchased and licensed patent rights		17		17
Internally developed patents		17		17
Trademarks		10		10

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and

further royalties, license fees or other amounts will be payable in the future under the license agreements.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

In addition to the purchased and licensed patents, the Company has capitalized legal and registration costs incurred to obtain and maintain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

Note 11 - Warrant Liabilities

12 Months Ended

Dec. 31, 2018

Warrant [Member]

Notes to Financial Statements

Derivatives and Fair Value [Text Block]

. Warrant Liabilities

Pursuant to FASB ASC

815,

the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of warrants.

During

June 2012,

the Company issued warrants to purchase a total of

15,000,000

shares of common stock to Visser Precision Cast, LLC under a Master Transaction Agreement (the “Visser MTA Agreement”). These warrants had an original exercise price of

$0.22

per share and an expiration date of

June 1, 2017

and were originally valued at

$4,260.

These warrants also had certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC

815.

As a result of subsequent issuances of the Company’s common stock, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to

$0.16

as of

March 22, 2017

and

December 31, 2016.

In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to

21,317,094

as of

March 22, 2017

and

December 31, 2016.

March 22, 2017

Visser Precision Cast exercised, on a cashless basis, all

21,317,094

warrants, resulting in the issuance of

4,241,386

shares of the Company’s common stock. Upon exercise, the Company reclassified

$975

of the associated warrant liability to additional paid in capital, with

being allocated to common stock and

$971

to additional paid in capital. The change in warrant value for these warrants for the years ended

December 31, 2018,

2017

and

2016

was a gain (loss) of

$0,

$553,

and (

$1,494

), respectively.

July 2, 2012,

the Company issued warrants to purchase a total of

18,750,000

shares of common stock as part of the

July 2012

Private Placement. These warrants have an exercise price of

$0.384

per share, expire on

January 2, 2018,

and were originally valued at

$5,053.

These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC

815.

As a result of contractually defined price resets, and issuances under the

2013,

2014,

and

2016

Purchase Agreements, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to

$0.17

and

$0.17

as of

December 31, 2017

and

December 31, 2016,

respectively. During the year ended

December 31, 2017

investors party to the

July 2012

Private Placement exercised a total of

10,540,750

warrants at an exercise price of

$0.17

per share. As a result of these warrant exercises, the Company issued

7,457,902

shares of common stock, for total consideration of

$712,

and associated warrant liabilities of

$1,247

were reclassified to additional paid in capital. The change in warrant value for these warrants for the years ended

December 31, 2018,

2017

and

2016

was a (loss) gain of

$0,

(

$551

), and (

$1,336

), respectively.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

March 10, 2016,

the Company issued warrants to purchase a total of

10,066,809

shares of common stock as part of the

2016

Purchase Agreement. These warrants have an exercise price of

$0.07

per share, expire on

March 10, 2026,

and were originally valued at

$760.

These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC

815.

As of

December 31, 2018,

these warrants were valued at

$925

under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of

7.19

years, (ii) volatility of

89%,

(iii) risk-free interest rate of

2.69%,

and (iv) dividend rate of

The change in fair value for these warrants for the years ended

December 31, 2018,

2017,

and

2016

was a gain (loss) of

$1,267,

(

$145

), and (

$1,287

), respectively.

The following table summarizes the change in the Company’s warrant liabilities for the year ended

December 31, 2018:

	Visser MTA			July 2, 2012			2016 Purchase
	Agreement			Private Placement			Agreement			Total

December 31, 2016	$	1,528		$	696		$	2,047		$	4,271
Change in value of warrant liabilities, (gain)		(553	)		551			145			143
Exercises		(975	)		(1,247	)		-			(2,222	)
December 31, 2017	$	-		$	-		$	2,192		$	2,192
Change in value of warrant liabilities, (gain)		-			-			(1,267	)		(1,267	)
Exercises		-			-			-			-
December 31, 2018	$	-		$	-		$	925		$	925

Included in current liabilities	$	-		$	-		$	-		$	-
Included in long-term liabilities	$	-		$	-		$	925		$	925

The Company had warrants to purchase

10,066,809

and

41,924,653

shares of common stock outstanding as of

December 31, 2018

and

December 31, 2017,

respectively, which were valued and classified as liabilities under FASB ASC

815.

The change in fair value of warrants resulted in a total non-cash (loss) gain of

$1,267,

(

$143

), and (

$4,117

) for the years ended

December 31, 2018,

2017,

and

2016,

respectively.

The fair value of warrants outstanding for the following periods was computed using the Black-Scholes model with the following range of assumptions:

	December 31,
	2018		2017		2016
Expected life in years		7.19		8.19		0.42	-	9.19
Volatility		89%		111%		76%	-	122%
Risk-free interest rate		2.7%		2.4%		0.6%	-	2.5%
Dividend rate		0%		0%			0%

As of

December 31, 2018,

outstanding warrants to acquire shares of the Company’s common stock are as follows:

Number of Shares		Exercise Price		Expiration Date

	10,066,809	$	0.07	March 10, 2026
	10,066,809

Note 12 - Option Liabilities	12 Months Ended
Note 12 - Option Liabilities	Dec. 31, 2018
Call Option [Member]
Notes to Financial Statements
Derivatives and Fair Value [Text Block]	1 2 . Option Liabilities As part of the 2016 Purchase Agreement, the Company granted the Investor the right to purchase shares of the Company’s common stock in the future at predetermined prices, of which the Investor was contractually obligated to effect following the satisfaction of certain conditions by the Company. These options allowed the Investor to purchase 200,000,000 shares of the Company’s common stock at a price of $0.15 per share and 100,000,000 shares of the Company’s common stock at a price of $0.25 per share. Given that the number of shares to be issued upon exercise of these options was in excess of the number of shares authorized for issuance, these options were originally required to be classified as liabilities under FASB ASC 815. The 200,000,000 share option and the 100,000,000 share option were initially valued at $489 and $22, respectively. Following the filing of an amendment to the Company’s Certificate of Incorporation, which allowed for adequate authorized shares, these options were revalued as of May 19, 2016 and reclassified to permanent shareholders’ equity. On May 19, 2016, the 200,000,000 share option and the 100,000,000 share option were valued at $2,931 and $193, respectively, under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.25 years, (ii) volatility of 85%, (iii) risk-free interest rate of 0.31%, and (iv) dividend rate of 0. The change in fair value for these options was a loss of $2,613 for the year ended December 31, 2016. LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) On August 11, 2016, the Company and the Investor entered into an amendment to the 2016 Purchase Agreement. Under the amendment, the Company agreed to extend the deadline for the Investor’s purchase of 300,000,000 additional shares of Company common stock under the 2016 Purchase Agreement from the original deadline of August 17, 2016 to a new deadline of December 31, 2016. Other than the extension of the deadline, the amendment did not materially modify the terms of the 2016 Purchase Agreement. As a result of this amendment the Company recorded an additional $2,126 of expense to additional paid in capital as a loss on contract modification during the year ended December 31, 2016. On October 26, 2016, the Investor fully exercised these options through the purchase of 300,000,000 shares of the Company’s common stock.

Note 14 - Shareholders' Equity	12 Months Ended
Note 14 - Shareholders' Equity	Dec. 31, 2018
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	1 4 . S hare holders’ Equity Common stock In connection with the execution of the 2016 Purchase Agreement, on March 10, 2016, the Company issued 105,000,000 shares of the Company’s common stock, at a price of $0.08 per share, for gross proceeds of $8,400. On May 19, 2016, the Company’s shareholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 700 million shares to 1,100 million shares. On October 26, 2016, the Company issued and sold to the Investor of the 2016 Purchase Agreement an aggregate of 300,000,000 shares of Company’s common stock for an aggregate purchase price of $55,000, comprised of 200,000,000 shares at a price of $0.15 per share and 100,000,000 shares at a price of $0.25 per share. In 2012, the Company entered into a non-exclusive engagement agreement with an investment banking firm. The services provided by the firm did not result in the identification of any practicable investment transactions and the agreement was considered effectively terminated by the Company in 2013. During 2016, the Company was notified by a representative of the firm stipulating that it did not consider the engagement agreement to be terminated and that previous financings and other funding transactions completed by the Company may be subject to success fees. In November 2016, the Company reached a settlement with respect to any and all amounts allegedly due under the engagement agreement in the amount of $750. Such amounts were reflected as a reduction of proceeds from stock issuances during the year ended December 31, 2016 and a corresponding reduction to additional paid in capital. Warrants In connection with the Series A Preferred Stock issuances in 2009, warrants to purchase 29,779,557 shares of the Company’s common stock, valued at $18,179, were outstanding through July 15, 2015. Due to extension of the expiration date of these warrants during 2010, they no longer contained anti-dilution provisions and were reflected as equity as they did not meet the criteria under FASB ASC 815 for liability treatment. Such warrants had exercise prices ranging between $0.48 and $0.49 and expired on July 15, 2015.

Note 15 - Stock Compensation Plan

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

. Stock Compensation Plan

April

2002,

our shareholders and Board of Directors adopted the

2002

Equity Incentive Plan (

“2002

Plan”). The

2002

Plan provides for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of

10,000,000

shares of our common stock

may

be granted under the

2002

Plan. The

2002

Plan expired by its terms in

April 2012,

but it will remain in effect only with respect to the equity awards that have been granted prior to its expiration. As of

December 31, 2018,

there were

169,000

options outstanding under the

2002

Plan.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

June 28, 2012,

the Company adopted the

2012

Equity Incentive Plan (

“2012

Plan”), with the approval of the shareholders, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The

2012

Plan provides for the granting to employees of incentive stock options within the meaning of Section

422

of the Internal Revenue Code of

1986,

as amended, and for the granting to employees and consultants of non-statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of

30,000,000

shares of the Company’s common stock

may

be granted under the

2012

Equity Incentive Plan, and all options granted under this plan had exercise prices that were equal to the fair market value on the date of grant. During

2018,

the Company granted options to purchase

1,217,175

shares of common stock, with total options outstanding of

11,755,503

as of

December 31, 2018.

January 27, 2015,

the Company adopted its

2015

Equity Incentive Plan (

“2015

Plan”), which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of

40,000,000

shares of the Company’s common stock are available for issuance under the

2015

Plan. All options granted under the

2015

Plan had exercise prices that were equal to the fair market value on the dates of grant. During

2018,

the Company granted options to purchase

7,910,000

shares of common stock, with total options outstanding of

16,906,667

as of

December 31, 2018.

FASB ASC

718,

Compensation – Stock Compensation,

requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under ASC

718,

Company is required to measure the cost of employee services received in exchange for stock options and similar awards based on the grant-date fair value of the award and recognize this cost in the income statement over the period during which an employee is required to provide service in exchange for the award. The Company recorded

$924,

$1,255,

and

$1,694

for the years ended

December 31, 2018,

2017,

and

2016,

respectively, of non-cash charges for stock compensation related to amortization of the fair value of restricted stock and unvested stock options. The total compensation costs related to non-vested awards

not

yet recognized were

$1,278,

$1,665,

and

$2,639

for the years ended

December 31, 2018,

2017,

and

2016,

respectively.

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions noted in the following table.

	December 31,
	2018				2017				2016

Expected volatility		64.92%	-	99.30%		45.20%	-	107.54%		56.48%	-	115.39%
Expected dividends			-				-				-
Expected term (in years)		0.50	-	6.20		.123	-	5.85		1.00	-	6.32
Risk-free rate		2.07%	-	2.97%		0.82%	-	2.06%		0.76%	-	2.13%

Expected volatilities are based on historical volatility expected over the expected life of the options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. Forfeiture rates of

23.43%,

19.86%

and

8.83%

were used for options granted during the years ended

December 31, 2018,

2017

and

2016,

respectively. The risk free rate for period within the expected life of the options is based on U.S. Treasury rates in effect at the time of grant.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

The following table summarizes the Company’s stock option transactions for the years ended

December 31, 2018

and

2017:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
								(in thousands)
Options outstanding at December 31, 2016		47,582,402			0.15
Granted		4,899,393			0.20
Exercised		(10,978,664	)		0.11
Forfeited		(7,052,137	)		0.15
Expired		(16,000	)		0.77
Options outstanding at December 31, 2017		34,434,994			0.17
Granted		9,127,175			0.17
Exercised		(5,438,716	)		0.09
Forfeited		(8,479,583	)		0.21
Expired		(812,700	)		0.29
Options outstanding at December 31, 2018		28,831,170		$	0.17		7.2	$	241
Options exercisable at December 31, 2018		15,212,177		$	0.18		5.8	$	177
Options unvested at December 31, 2018		13,618,993		$	0.17		8.8	$	64
Options vested or expected to vest at December 31, 2018		25,279,870		$	0.17		6.9	$	235

The following table provides supplemental data on stock options for the years ended

December 31, 2018,

2017

and

2016:

	December 31,
	2018		2017		2016

Weighted average grant date fair value per option granted	$	0.13	$	0.18	$	0.08
Fair value of options vested		911		1,192		2,022
Cash from participants to exercise stock options		463		1,238		206
Intrinsic value of options exercised		537		2,271		221

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

The following table summarizes the Company’s stock options outstanding and exercisable by ranges of option prices as of

December 31, 2018:

Options Outstanding										Options Exercisable
Range of Exercise Prices				Numbers of Options Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price

	$0.00	-	0.10		6,897,943		5.91	$	0.08		5,165,194		5.53	$	0.08
	0.11	-	0.38		21,933,227		7.64		0.20		10,046,983		5.87		0.23

		Total			28,831,170						15,212,177

The Company’s non-vested options at the beginning and ending of fiscal year

2018

had weighted-average grant-date fair values of

$0.15

and

$0.14

per option, respectively.

In connection with the separation of former executives and directors, the Company has modified previously granted equity awards to allow for the acceleration of vesting of equity awards, and the extension of the timing to exercise vested awards, following the respective separation dates. The Company incurred incremental stock-based compensation expense of

$66,

$261,

and

$367

during the years ended

December 31, 2018,

2017,

and

2016,

respectively.

Note 16 - Income Taxes

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Income Tax Disclosure [Text Block]

. Income Taxes

Significant components of deferred tax assets are as follows:

	Years Ended December 31,
	2018			2017
Loss carry forwards	$	33,733		$	39,304
Derivative valuations		259			521
NQSO		1,964			1,794
Tax Credits		331			382
Other		107			(54	)
Total deferred tax asset		36,394			41,947

Valuation allowance		(36,394	)		(41,947	)
Total deferred tax asset, net		-			-

The valuation allowance decreased

$5,553

and

$18,383

2018

and

2017,

respectively. On

December 22, 2017,

the Tax Cuts and Jobs Act (“Tax Reform”) was signed into law. This comprehensive reform of tax law reduces the federal corporate income tax rate from

34%

21%

and is generally effective beginning

January 1, 2018.

US GAAP requires deferred tax assets and liabilities to be measured at the enacted tax rate expected to apply when temporary differences are to be realized or settled. At the date of enactment, the Company’s deferred taxes were remeasured based upon the new tax rate and were reduced by

$20,531,

with a corresponding decrease to the valuation allowance. Changes in the valuation allowance are also impacted by the expiration of net operating loss (“NOL”) carryforwards, current year net operating losses, and changes to future tax deductions resulting from derivative valuations, the terms of stock compensation plans, and accrued liabilities.

LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

The following table accounts for the differences between the expected federal tax benefit (based on the statutory

2018

U.S. federal income tax rate of

21%

) and the actual tax provision:

	Years Ended December 31,
	2018			2017			2016
Expected federal tax benefit		-21.0	%		-34.0	%		-34.0	%
Permanent items		0.9	%		1.7	%		5.6	%
Net operating loss utilized or expired		0.0	%		0.0	%		0.0	%
Increase in valuation allowance and others		20.1	%		32.3	%		28.4	%

Effective tax rate		0	%		0	%		0	%

As of

December 31, 2018,

the Company had approximately

$130.7

million of NOL carryforwards for U.S. federal income tax purposes expiring in

2019

through

2038.

As a result of Tax Reform, the Company’s federal net operating losses continue to be-measured at

21%.

The reduction in the federal corporate income tax rate does

not

change the gross dollar value of taxable income that

may

be offset by NOLs, however that taxable income will only be taxable at

21%

in future periods, thus reducing the value of NOLs utilized after

2018.

As of

December 31, 2018,

the Company had approximately

$90.0

million of NOL carryforwards for California income tax purposes expiring in

2019

through

2038,

respectively. The Company and Liquidmetal Golf, Inc. file on a separate company basis for federal income tax purposes. Accordingly, the federal NOL carryforwards of

one

legal entity are

not

available to offset federal taxable income of the other. Liquidmetal Golf, Inc. had approximately

$36.2

million in federal NOL carryforwards, expiring in

2019

through

2038.

We recognize excess tax benefits associated with the exercise of stock options directly to shareholders’ equity only when realized. Accordingly, deferred tax assets are

not

recognized for NOL carryforwards resulting from excess tax benefits. As of

December 31, 2018,

deferred tax assets do

not

include approximately

$325

of these tax effected excess tax benefits from employee stock option exercise that are a component of our NOL carryforwards. Accordingly, additional paid-in capital will increase up to an additional

$325

if and when such excess tax benefits are realized.

As of

December 31, 2018,

the Company had approximately

$138

of Research & Development (“R&D”) credit carryforwards for U.S. federal income tax purposes expiring in

2019

through

2030.

In addition, the Company has California R&D credit carryforwards of approximately

$243,

which do

not

expire under current California law. Tax Reform did

not

impact the valuation of tax credit carryforwards, which directly offset taxes due.

Section

382

of the Internal Revenue Code (“IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. As a result of the completion of the complex analysis required by the IRC to determine if an ownership change has occurred, the Company has determined that its annual NOL carryforward limitation under Section

382

of the IRC is

$764

per year.

The ability to realize the tax benefits associated with deferred tax assets, which includes benefits related to NOL’s, is principally dependent upon the Company’s ability to generate future taxable income from operations. The Company has provided a full valuation allowance for its net deferred tax assets due to the Company’s net operating losses.

The Company adopted the provisions of FASB ASC Topic

470

– Income Taxes. At the adoption date and as of

December 31, 2018,

the Company had

material unrecognized tax benefits and

adjustments to liabilities or operations were required. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense which were

for the years ended

December 31, 2018,

2017

and

2016.

As of

December 31, 2018,

the tax years

2014

through

2018,

and

2013

through

2018

are subject to examination by the federal and California taxing authorities, respectively.

Note 17 - Loss Per Common Share	12 Months Ended
Note 17 - Loss Per Common Share	Dec. 31, 2018
Notes to Financial Statements
Earnings Per Share [Text Block]	1 7 . Loss Per Common Share Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings. Options to purchase 28,831,170 shares of common stock at prices ranging from $0.07 to $0.38 per share were outstanding at December 31, 2018, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 34,434,994 shares of common stock at prices ranging from $0.07 to $0.47 per share were outstanding at December 31, 2017, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 47,582,402 shares of common stock at prices ranging from $0.07 to $0.77 per share were outstanding at December 31, 2016, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) Warrants to purchase 10,066,809 shares of common stock, priced at $0.07 per share, outstanding at December 31, 2018 and December 31, 2017 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 41,924,653 shares of common stock, with prices ranging from $0.07 to $0.17 per share, outstanding at December 31, 2016 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

Note 21 - Related Party Transactions	12 Months Ended
Note 21 - Related Party Transactions	Dec. 31, 2018
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	21 . Related Party Transactions On November 17, 2016, the Company and Thomas Steipp, the former Company’s President and Chief Executive Officer, entered into a Separation and Mutual Release Agreement pursuant to which Mr. Steipp resigned as an officer, director, and employee of the Company (the “Separation Agreement”). The Separation Agreement provided for the payment of severance compensation to Mr. Steipp in the form of a lump sum of $300 (subject to tax withholdings) and reimbursement for COBRA healthcare coverage for a period of 12 months. In addition, it provided for the accelerated vesting of 3,990,400 of the 9,939,451 unvested stock options held by Mr. Steipp as of the separation date and the extension of the exercise period of his options until the second anniversary of the date of the Separation Agreement. This resulted in a total of 10,777,949 stock options being exercisable by Mr. Steipp as of the separation date and resulted in an additional $297 of stock-based compensation expense during the year ended December 31, 2016. In connection with the Separation Agreement, Mr. Steipp and the Company granted each other mutual general releases subject to customary exceptions. As of December 31, 2018 and December 31, 2017, the Company had accrued liabilities totaling $0 and $0, respectively, relating to the Separation Agreement. On August 16, 2017, the Company and Tony Chung, the Company’s former Chief Financial Officer, entered into a Separation Agreement and General Release pursuant to which Mr. Chung resigned as an officer and employee of the Company (the “Chung Separation Agreement”). Concurrently, Mr. Chung was elected to serve as a director of the Company. The Chung Separation Agreement provided for the payment of severance compensation to Mr. Chung in the form of a continuation of his base annual salary of $240 (subject to tax withholdings) for a period of 12 months and reimbursement for COBRA healthcare coverage for a period of 12 months. In addition, it provided for the accelerated vesting of 247,650 of the unvested stock options held by Mr. Chung as of the separation date and the extension of the exercise period of his options until the first anniversary of the date of the Chung Separation Agreement. This resulted in a total of 2,889,749 stock options being exercisable by Mr. Chung as of the separation date and resulted in an additional $89 of stock-based compensation expense during the year ended December 31, 2017. In connection with the Chung Separation Agreement, Mr. Chung and the Company granted each other mutual general releases subject to customary exceptions. Subsequently, the Company extended the exercise period of Mr. Chung's options to the second anniversary of the date of the Chung Separation Agreement. This resulted in an additional $48 of stock-based compensation expense during the year ended December 31, 2018. As of December 31, 2018 and December 31, 2017, the Company had accrued liabilities totaling $0 and $164, respectively, relating to the Chung Separation Agreement. LIQUIDMETAL TECHNOLOGIES, INC AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share data) On March 10, 2016, the Company entered into the 2016 Purchase Agreement with Liquidmetal Technology Limited, providing for the purchase of 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. Liquidmetal Technology Limited is a company owned by Professor Li that was formed in 2016 in contemplation of the 2016 Purchase Agreement. In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and Eontec, entered into a license agreement pursuant to which the Company and Eontec entered into a cross-license of their respective technologies. Eontec is a publicly held Hong Kong corporation of which Professor Li is the Chairman and major shareholder. As of December 31, 2018, Professor Li is a greater-than 5% beneficial owner of the Company’s common stock and served (and currently serves) as the Company’s Chairman, President, and Chief Executive Officer. Equipment and services procured from Eontec were $213, $877, and $68 during the years ended December 31, 2018, 2017, and 2017, respectively.

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation.

The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc., its special-purpose wholly-owned subsidiary, Crucible Intellectual Property LLC,

20321

Valencia LLC, and Liquidmetal Golf. All intercompany balances and transactions have been eliminated.

Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]

Non-

ontrolling

nterest.

The results of operations attributable to the non-controlling interest of Liquidmetal Golf are presented within equity and are shown separately from the Company’s equity.

Revenue from Contract with Customer [Policy Text Block]

Revenue Recognition

. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic

606

(“ASC

605”

), Revenue from Contracts with Customers. ASC

606

The Company’s revenue recognition policy complies with the requirements of ASC

606.

As a majority of the Company’s sales revenue continues to be recognized when products are shipped from its manufacturing facility, and there was

change in the recognition model historically applied to active license and royalty contracts under the new revenue standard, there was

adjustment to the opening balance of retained earnings. The impact to the Company’s results of operations is

not

Products

not

expected to be material on an ongoing basis.

Licensing and royalties

may

be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time. Licensing revenues that are

one

further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Practical Expedients and Exemptions

. The Company generally expenses sales commissions when incurred because the amortization period would have been

one

year or less. These costs are recorded within selling, marketing, general and administrative expenses. The Company does

not

disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of

one

year or less and (ii) contracts for which the Company recognizes revenue at the amount for which it has the right to invoice for services performed.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash

and cash equivalents

The Company considers all highly liquid investments with maturity dates of

three

not

experienced any losses related to these balances and believes its credit risk to be minimal. As of

December 31, 2018

and

2017,

the Company held deposits of

$15,187

and

respectively, in such highly liquid investments.

Receivables, Policy [Policy Text Block]

Trade Accounts Receivable.

December 31, 2018,

three

customers represented

90%,

$108,

of the total outstanding trade accounts receivable. As of

December 31, 2017,

three

customers represented

84%,

$131,

of the total outstanding trade accounts receivable. During

2018,

there were

three

major customers, who together accounted for

66%

of total revenue. During

2017,

there were

five

major customers, who together accounted for

63%

of total revenue. During

2016,

there were

three

major customers, who together accounted for

73%

of total revenue. In the future, the Company expects that a significant portion of the revenue

may

continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.

December 31, 2018

and

2017,

the Company had

not

recorded an allowance for doubtful accounts.

Inventory, Policy [Policy Text Block]

Inventory.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment.

one

five

years.

Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]

Intangible Assets.

ten

seventeen

years.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Long-lived Assets

. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset

may

be impaired. These evaluations

may

impairment charges have been recognized during the years ended

December 31, 2018,

2017,

and

2016,

respectively.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value

Measurements.

instruments within the fair value hierarchy.

Level

—

Quoted prices in active markets for identical assets or liabilities;

Level

—

Observable inputs other than Level

prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are

not

active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level

—

Unobservable inputs that are supported by little or

market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level

measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic

480

10,

FASB ASC Paragraph

815

and FASB ASC Subparagraph

815

and

As of

December 31, 2018,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		-		-		-		-
Warrant liabilities (long-term)		925		-		925		-

As of

December 31, 2017,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		-		-		-		-
Warrant liabilities (long-term)		2,192		-		2,192		-

Research and Development Expense, Policy [Policy Text Block]

Research and Development Expenses.

Advertising Costs, Policy [Policy Text Block]

Advertising and Promotion Expenses.

Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were

$125,

$154

and

$83,

for the years ended

December 31, 2018,

2017

and

2016,

respectively.

Legal Costs, Policy [Policy Text Block]

Legal Costs.

Legal costs are expensed as incurred.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock-Based Compensation

. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic

718,

Share-based Payment

may

differ materially in the future from that recorded in the current period.

Income Tax, Policy [Policy Text Block]

Income Taxes.

Income taxes are provided under the asset and liability method as required by FASB ASC Topic

740,

Accounting for Income Taxes

740,

the Company had

material unrecognized tax positions and

adjustments to liabilities or operations were required. The Company, when applicable, will recognize interest and penalties related to uncertain tax positions in income tax expense. There was

expense related to interest and penalties for the years ended

December 31, 2018,

2017

and

2016,

respectively.

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates.

Subsequent Events, Policy [Policy Text Block]

Subsequent Events.

The Company evaluated subsequent events through the filing of its Annual Report on Form

-K with the SEC.

Supplemental Cash Flow Information, Policy [Policy Text Block]

Supplemental Cash Flow Information.

Cash payments for interest were

$0,

and

in the years ended

December 31, 2018,

2017,

and

2016,

respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements.

Leases

February 2016,

December 15, 2018

and is required to be applied retrospectively to all leasing arrangements. The adoption of this guidance is

not

expected to have a significant impact on the Company’s consolidated financial statements.

Liability Classified Warrants

July 2017,

December 15, 2018

first

quarter of the year ending

December 31, 2019.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did

not

or are

not

believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 8 - Patents and Trademarks, Net (Tables)

12 Months Ended

Dec. 31, 2018

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	December 31,
	2018			2017

Purchased and licensed patent rights	$	566		$	566
Internally developed patents		1,686			1,686
Trademarks		148			148
Total		2,400			2,400
Accumulated amortization	$	(2,078	)	$	(1,992	)
Total intangible assets, net	$	322		$	408

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

December 31,	Aggregate Amortization Expense

2019	$	84
2020		81
2021		56
2022		29
2023		20
Thereafter		52
	$	322

Finite-lived Intangible Assets, Accumulated Amortization [Table Text Block]

	December 31,
	2018			2017

Purchased and licensed patent rights	$	(548	)	$	(541	)
Internally developed patents		(1,400	)		(1,326	)
Trademarks		(130	)		(125	)
Total	$	(2,078	)	$	(1,992	)

Finite-lived Intangible Assets, Weighted Average Amortization Periods [Table Text Block]

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); margin-left: 0pt; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div><div style=" background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="2" rowspan="1" style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); text-align: center; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">2017</div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); padding-bottom: 1px;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;">Purchased and licensed patent rights</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Internally developed patents</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Trademarks</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

Note 11 - Warrant Liabilities (Tables)

12 Months Ended

Dec. 31, 2018

Notes Tables

Fair Value Assumptions used for Warrants Outstanding [Table Text Block]

	December 31,
	2018		2017		2016
Expected life in years		7.19		8.19		0.42	-	9.19
Volatility		89%		111%		76%	-	122%
Risk-free interest rate		2.7%		2.4%		0.6%	-	2.5%
Dividend rate		0%		0%			0%

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Number of Shares		Exercise Price		Expiration Date

	10,066,809	$	0.07	March 10, 2026
	10,066,809

Warrant [Member]

Notes Tables

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

	Visser MTA			July 2, 2012			2016 Purchase
	Agreement			Private Placement			Agreement			Total

December 31, 2016	$	1,528		$	696		$	2,047		$	4,271
Change in value of warrant liabilities, (gain)		(553	)		551			145			143
Exercises		(975	)		(1,247	)		-			(2,222	)
December 31, 2017	$	-		$	-		$	2,192		$	2,192
Change in value of warrant liabilities, (gain)		-			-			(1,267	)		(1,267	)
Exercises		-			-			-			-
December 31, 2018	$	-		$	-		$	925		$	925

Included in current liabilities	$	-		$	-		$	-		$	-
Included in long-term liabilities	$	-		$	-		$	925		$	925

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

Note 15 - Stock Compensation Plan (Tables)

12 Months Ended

Dec. 31, 2018

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	December 31,
	2018				2017				2016

Expected volatility		64.92%	-	99.30%		45.20%	-	107.54%		56.48%	-	115.39%
Expected dividends			-				-				-
Expected term (in years)		0.50	-	6.20		.123	-	5.85		1.00	-	6.32
Risk-free rate		2.07%	-	2.97%		0.82%	-	2.06%		0.76%	-	2.13%

Share-based Compensation, Stock Options, Activity [Table Text Block]

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
								(in thousands)
Options outstanding at December 31, 2016		47,582,402			0.15
Granted		4,899,393			0.20
Exercised		(10,978,664	)		0.11
Forfeited		(7,052,137	)		0.15
Expired		(16,000	)		0.77
Options outstanding at December 31, 2017		34,434,994			0.17
Granted		9,127,175			0.17
Exercised		(5,438,716	)		0.09
Forfeited		(8,479,583	)		0.21
Expired		(812,700	)		0.29
Options outstanding at December 31, 2018		28,831,170		$	0.17		7.2	$	241
Options exercisable at December 31, 2018		15,212,177		$	0.18		5.8	$	177
Options unvested at December 31, 2018		13,618,993		$	0.17		8.8	$	64
Options vested or expected to vest at December 31, 2018		25,279,870		$	0.17		6.9	$	235

Schedule of Supplemental Stock Option Data [Table Text Block]

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); margin-left: 0pt; border-bottom: thin solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></div><div style=" background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255); padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 55%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average grant date fair value per option granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.08</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Fair value of options vested</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">911</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,192</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,022</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash from participants to exercise stock options</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">463</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,238</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">206</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Intrinsic value of options exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">537</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,271</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">221</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Options Outstanding										Options Exercisable
Range of Exercise Prices				Numbers of Options Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price

	$0.00	-	0.10		6,897,943		5.91	$	0.08		5,165,194		5.53	$	0.08
	0.11	-	0.38		21,933,227		7.64		0.20		10,046,983		5.87		0.23

		Total			28,831,170						15,212,177

Note 16 - Income Taxes (Tables)

12 Months Ended

Dec. 31, 2018

Notes Tables

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	Years Ended December 31,
	2018			2017
Loss carry forwards	$	33,733		$	39,304
Derivative valuations		259			521
NQSO		1,964			1,794
Tax Credits		331			382
Other		107			(54	)
Total deferred tax asset		36,394			41,947

Valuation allowance		(36,394	)		(41,947	)
Total deferred tax asset, net		-			-

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Years Ended December 31,
	2018			2017			2016
Expected federal tax benefit		-21.0	%		-34.0	%		-34.0	%
Permanent items		0.9	%		1.7	%		5.6	%
Net operating loss utilized or expired		0.0	%		0.0	%		0.0	%
Increase in valuation allowance and others		20.1	%		32.3	%		28.4	%

Effective tax rate		0	%		0	%		0	%

Note 2 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)
Cash Equivalents, at Carrying Value, Total	$ 15,187,000	$ 0
Accounts Receivable, Gross, Current	120,000	157,000
Allowance for Doubtful Accounts Receivable, Current, Ending Balance	0	0
Impairment of Long-Lived Assets Held-for-use	0	0	$ 0
Advertising Expense	125,000	154,000	83,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total	0	0	0
Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total	$ 0	0	$ 9,000
Minimum [Member]
Property, Plant and Equipment, Useful Life	1 year
Finite-Lived Intangible Asset, Useful Life	10 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	5 years
Finite-Lived Intangible Asset, Useful Life	17 years
Customer Concentration Risk [Member] \| Three Major Customers [Member]
Accounts Receivable, Gross, Current	$ 108,000	$ 131,000
Customer Concentration Risk [Member] \| Accounts Receivable [Member]
Concentration Risk, Number of Major Customers	3	3
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Three Major Customers [Member]
Concentration Risk, Percentage	90.00%	84.00%
Customer Concentration Risk [Member] \| Sales Revenue, Goods, Net [Member]
Concentration Risk, Number of Major Customers	3	5	3
Customer Concentration Risk [Member] \| Sales Revenue, Goods, Net [Member] \| Three Major Customers [Member]
Concentration Risk, Percentage	66.00%	63.00%	73.00%

Note 2 - Summary of Significant Accounting Policies - Fair Value of Items Measured on a Recurring Basis (Details) - Warrant [Member] - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Derivative Liability, Current
Derivative Liability, Noncurrent	925	2,192
Fair Value, Measurements, Recurring [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent	925	2,192
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent	925	2,192
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent

Note 3 - Significant Transactions (Details Textual)														12 Months Ended
Note 3 - Significant Transactions (Details Textual)	Feb. 16, 2017 USD ($) ft²	Oct. 26, 2016 USD ($) $ / shares shares	Aug. 25, 2016 USD ($)	Mar. 10, 2016 USD ($) $ / shares shares	Mar. 09, 2016 USD ($) $ / shares shares	Feb. 28, 2015 USD ($)	Aug. 22, 2014 USD ($) $ / shares shares	Aug. 20, 2014 USD ($) $ / shares	Dec. 06, 2013	Nov. 08, 2013 USD ($) shares	Jul. 17, 2013 shares	Jul. 02, 2012 USD ($) $ / shares shares	Jan. 31, 2012	Dec. 31, 2018 USD ($) $ / shares	Dec. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 USD ($) $ / shares shares	Mar. 31, 2017 USD ($)	Mar. 22, 2017 $ / shares shares	May 19, 2016 $ / shares shares	Jun. 30, 2012 $ / shares shares	Jun. 01, 2012 $ / shares shares
Area of Land \| ft²	41,000
Stock Issued During Period, Value, New Issues \| $																$ 61,379,000
Common Stock, Par or Stated Value Per Share \| $ / shares														$ 0.001	$ 0.001
Proceeds from Issuance of Common Stock \| $																62,650,000
Interest Expense, Total \| $																9,000
Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity \| $						$ 2,000,000
Line of Credit Facility, Interest Rate During Period						2.10%								2.10%
Interest Expense, Total \| $														$ 0	$ 0	$ 9,000
Line of Credit [Member] \| Collateral Pledged [Member] \| Cash [Member]
Line of Credit Facility, Collateral Fees, Amount \| $			$ 1,000,000
Eontec [Member]
Purchase Price for Machinery and Equipment \| $																	$ 780,000
Warrants in Connection with the 2016 Purchase Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares				10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares		$ 0.07		$ 0.07
Warrants and Rights Outstanding, Term		10 years
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Vest on March 10, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares				2,609,913
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Vest on October 26, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares		7,456,896
July 2012 Private Placement Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares												18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares												$ 0.384			$ 0.17	$ 0.17
Warrants in Connection with Vissar MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares															21,317,094	21,317,094		21,317,094		15,000,000	15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares															$ 0.16	$ 0.16		$ 0.16		$ 0.22	$ 0.22
Common Stock [Member]
Stock Issued During Period, Shares, New Issues \| shares																405,000,000
Stock Issued During Period, Value, New Issues \| $																$ 405,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors \| shares				405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors \| $				$ 63,400,000
Stock Issued During Period, Shares, New Issues \| shares		300,000,000		105,000,000
Stock Issued During Period, Value, New Issues \| $		$ 55,000,000		$ 8,400,000
Sale of Stock, Price Per Share \| $ / shares				$ 0.08
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions \| $ / shares		$ 0.15																	$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions \| $ / shares		$ 0.25																	$ 0.25
Common Stock Purchase Agreement, Value of Shares Authorized to Be Purchased No Later than 90 Days after Satisfaction of Certain Conditions \| $		$ 55,000,000
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.15 [Member]
Stock Issued During Period, Shares, New Issues \| shares		200,000,000
Sale of Stock, Price Per Share \| $ / shares		$ 0.15
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions \| shares		200,000,000																	200,000,000
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.25 [ Member]
Stock Issued During Period, Shares, New Issues \| shares		100,000,000
Sale of Stock, Price Per Share \| $ / shares		$ 0.25
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions \| shares		100,000,000																	100,000,000
The 2014 Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors \| $								$ 30,000,000
Common Stock, Par or Stated Value Per Share \| $ / shares								$ 0.001
Common Stock Subscriptions, Term								3 years
Proceeds from Issuance of Common Stock \| $					$ 1,568,000
The 2014 Purchase Agreement [Member] \| Common Stock [Member]
Stock Issued During Period, Shares, New Issues \| shares					12,500,000
Stock Issued During Period, Weighted Average Price Per Share \| $ / shares					$ 0.13
Common Stock Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors \| $										$ 20,000,000
Stock Issued During Period, Shares, New Issues \| shares							85,355,615
Stock Issued During Period, Value, New Issues \| $							$ 16,000,000
Common Stock Subscriptions, Term										3 years
Stock Issued During Period, Weighted Average Price Per Share \| $ / shares							$ 0.19
Stock Issued During Period, Shares, Other \| shares										2,666,667
Private Placement [Member] \| Convertible Notes Payable [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares												18,750,000
Debt Instrument, Face Amount \| $												$ 12,000,000
Debt Instrument, Convertible, Conversion Price \| $ / shares												$ 0.352
Debt Instrument, Interest Rate, Stated Percentage												8.00%
Debt Instrument, Term												1 year
Debt Conversion, Converted Instrument, Shares Issued \| shares											163,641,547
Liquidmetal Technology Limited [Member] \| Lugee Li [Member]
Ownership Percentage				100.00%
Liquidmetal Golf [Member]
Noncontrolling Interest, Ownership Percentage by Parent														79.00%
Valencia Circle, LLC [Member]
Payments to Acquire Buildings \| $	$ 7,818,000
Engel [Member]
Supply and License Agreement, Term													5 years
Exclusive License Agreement, Term									10 years

Note 4 - Trade Accounts Receivable - Trade Accounts Receivable Table (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Trade accounts receivable	$ 120,000	$ 157,000
Less: Allowance for doubtful accounts	0	0
Trade accounts receivable	$ 120,000	$ 157,000

Note 5 - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Prepaid service invoices	$ 79	$ 116
Prepaid manufacturing and mold costs	91
Prepaid insurance premiums	193	210
Total	$ 363	$ 326

Note 6 - Inventory (Details Textual) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Jul. 30, 2018	Dec. 31, 2017	Dec. 31, 2018
Inventory, Net, Total		$ 391	$ 31
Inventory Write-down	$ 642	$ 279

Note 6 - Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Raw materials		$ 367
Work in progress	31	24
Total	$ 31	$ 391

Note 7 - Property and Equipment (Details Textual)		12 Months Ended
Note 7 - Property and Equipment (Details Textual)	Feb. 16, 2017 USD ($) ft²	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Mar. 31, 2017 USD ($)
Depreciation, Total		$ 992,000	$ 548,000	$ 429,000
Eontec [Member]
Purchase Price for Machinery and Equipment					$ 780,000
Valencia Circle, LLC [Member]
Area of Real Estate Property \| ft²	41,000
Payments to Acquire Buildings	$ 7,818,000
Cost of Sales [Member]
Depreciation, Total		76,000	42,000	20,000
Selling, General and Administrative Expenses [Member]
Depreciation, Total		$ 916,000	$ 506,000	$ 409,000

Note 7 - Property and Equipment - Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Property and equipment, gross	$ 15,247	$ 14,958
Accumulated depreciation	(3,480)	(2,493)
Total property and equipment, net	11,767	12,465
Land, Buildings and Improvements [Member]
Property and equipment, gross	9,039	8,947
Machinery and Equipment [Member]
Property and equipment, gross	5,745	5,577
Computer Equipment [Member]
Property and equipment, gross	282	253
Office Equipment, Furnishings and Improvements [Member]
Property and equipment, gross	$ 181	$ 181

Note 8 - Patents and Trademarks, Net - Patents and Trademarks (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Intangible assets, gross	$ 2,400	$ 2,400
Accumulated amortization	(2,078)	(1,992)
	322	408
Purchased and Licensed Patent Rights [Member]
Intangible assets, gross	566	566
Accumulated amortization	(548)	(541)
Internally Developed Patents [Member]
Intangible assets, gross	1,686	1,686
Accumulated amortization	(1,400)	(1,326)
Trademarks [Member]
Intangible assets, gross	148	148
Accumulated amortization	$ (130)	$ (125)

Note 8 - Patents and Trademarks, Net - Estimated Future Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
2019	$ 84
2020	81
2021	56
2022	29
2023	20
Thereafter	52
	$ 322	$ 408

Note 9 - Short-term Debt (Details Textual) - USD ($)		12 Months Ended
Note 9 - Short-term Debt (Details Textual) - USD ($)	Feb. 28, 2015	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Short-term Debt, Total
Interest Expense, Total				$ 9,000
Line of Credit [Member]
Short-term Debt, Total		$ 0	0
Line of Credit Facility, Interest Rate During Period	2.10%	2.10%
Interest Expense, Total		$ 0	$ 0	$ 9,000

Note 10 - Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accrued payroll, vacation, and bonuses	$ 178	$ 149
Accrued severance	10	164
Accrued audit fees	82	52
Total	$ 270	$ 365

Note 11 - Warrant Liabilities (Details Textual)		12 Months Ended
Note 11 - Warrant Liabilities (Details Textual)	Mar. 22, 2017 USD ($) $ / shares shares	Dec. 31, 2018 USD ($) shares	Dec. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 USD ($) $ / shares shares	Oct. 26, 2016 $ / shares	Mar. 10, 2016 USD ($) $ / shares shares	Jul. 02, 2012 USD ($) $ / shares shares	Jun. 30, 2012 USD ($) $ / shares shares	Jun. 01, 2012 $ / shares shares
Stock Issued During Period, Value, Warrants Exercised in Period			$ 2,934,000	$ 665,000
Fair Value Adjustment of Warrants		$ (1,267,000)	143,000	4,117,000
Proceeds from Warrant Exercises			$ 712,000
Class of Warrant or Right, Outstanding \| shares		10,066,809	41,924,653
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input		7.19	8.19
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input		0.89	1.11
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input		0.027	0.024
Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input		0	0	0
Warrant [Member]
Derivative Liability, Noncurrent		$ 925,000	$ 2,192,000
Decrease in Warrant Liability, Warrants Exercised			2,222,000
Fair Value Adjustment of Warrants		(1,267,000)	$ 143,000
Common Stock [Member]
Stock Issued During Period, Shares, Warrants Exercised in Period \| shares			11,699,288	1,743,480
Stock Issued During Period, Value, Warrants Exercised in Period			$ 12,000	$ 2,000
Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Warrants Exercised in Period			$ 2,922,000	$ 663,000
Warrants in Connection with Vissar MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares	21,317,094		21,317,094	21,317,094				15,000,000	15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 0.16		$ 0.16	$ 0.16				$ 0.22	$ 0.22
Derivative Liability, Noncurrent								$ 4,260,000
Stock Issued During Period, Shares, Warrants Exercised in Period \| shares	4,241,386
Decrease in Warrant Liability, Warrants Exercised	$ 975,000
Fair Value Adjustment of Warrants		0	$ 553,000	$ (1,494,000)
Warrants in Connection with Vissar MTA Agreement [Member] \| Common Stock [Member]
Stock Issued During Period, Value, Warrants Exercised in Period	4,000
Warrants in Connection with Vissar MTA Agreement [Member] \| Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Warrants Exercised in Period	$ 971,000
July 2012 Private Placement Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares							18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares			$ 0.17	$ 0.17			$ 0.384
Stock Issued During Period, Shares, Warrants Exercised in Period \| shares			7,457,902
Decrease in Warrant Liability, Warrants Exercised			$ 1,247,000
Fair Value Adjustment of Warrants		0	$ (551,000)	$ (1,336,000)
Class Of Warrant Or Right Exercised in Period \| shares			10,540,750
Proceeds from Warrant Exercises			$ 712,000
July 2012 Private Placement Warrants [Member] \| Warrant [Member]
Derivative Liability, Noncurrent							$ 5,053,000
Warrants in Connection with the 2016 Purchase Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares						10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares					$ 0.07	$ 0.07
Fair Value Adjustment of Warrants		$ 1,267,000	$ (145,000)	$ (1,287,000)
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input		7.19
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input		0.89
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input		0.0269
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input		0
Warrants in Connection with the 2016 Purchase Agreement [Member] \| Warrant [Member]
Derivative Liability, Noncurrent		$ 925,000				$ 760,000

Note 11 - Warrant Liabilities - Summary of Changes in Warrant Liabilities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Loss (gain) from change in value of warrants	$ (1,267,000)	$ 143,000	$ 4,117,000
Warrant [Member]
Derivative liabilities, balance	2,192,000	4,271,000
Loss (gain) from change in value of warrants	(1,267,000)	143,000
Exercises		(2,222,000)
Derivative liabilities, balance	925,000	2,192,000	4,271,000
Included in current liabilities
Derivative Liability, Noncurrent	925,000	2,192,000
Warrant [Member] \| Visser MTA Agreement [Member]
Derivative liabilities, balance		1,528,000
Loss (gain) from change in value of warrants		(553,000)
Exercises		(975,000)
Derivative liabilities, balance			1,528,000
Included in current liabilities
Derivative Liability, Noncurrent
Warrant [Member] \| Private Placement [Member]
Derivative liabilities, balance		696,000
Loss (gain) from change in value of warrants		551,000
Exercises		(1,247,000)
Derivative liabilities, balance			696,000
Included in current liabilities
Derivative Liability, Noncurrent
Warrant [Member] \| The 2016 Purchase Agreement [Member]
Derivative liabilities, balance	2,192,000	2,047,000
Loss (gain) from change in value of warrants	(1,267,000)	145,000
Exercises
Derivative liabilities, balance	925,000	$ 2,192,000	$ 2,047,000
Included in current liabilities
Derivative Liability, Noncurrent	$ 925,000

Note 11 - Warrant Liabilities - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding (Details)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Measurement Input, Expected Term [Member]
Warrant liabilities, measurement input	7.19	8.19
Measurement Input, Expected Term [Member] \| Minimum [Member]
Warrant liabilities, measurement input			0.42
Measurement Input, Expected Term [Member] \| Maximum [Member]
Warrant liabilities, measurement input			9.19
Measurement Input, Price Volatility [Member]
Warrant liabilities, measurement input	0.89	1.11
Measurement Input, Price Volatility [Member] \| Minimum [Member]
Warrant liabilities, measurement input			0.76
Measurement Input, Price Volatility [Member] \| Maximum [Member]
Warrant liabilities, measurement input			1.22
Measurement Input, Risk Free Interest Rate [Member]
Warrant liabilities, measurement input	0.027	0.024
Measurement Input, Risk Free Interest Rate [Member] \| Minimum [Member]
Warrant liabilities, measurement input			0.006
Measurement Input, Risk Free Interest Rate [Member] \| Maximum [Member]
Warrant liabilities, measurement input			0.025
Measurement Input, Expected Dividend Rate [Member]
Warrant liabilities, measurement input	0	0	0
Measurement Input, Expected Dividend Rate [Member] \| Minimum [Member]
Warrant liabilities, measurement input
Measurement Input, Expected Dividend Rate [Member] \| Maximum [Member]
Warrant liabilities, measurement input

Note 12 - Option Liabilities (Details Textual) $ / shares in Units, $ in Thousands				12 Months Ended
	Oct. 26, 2016 $ / shares shares	May 19, 2016 USD ($) $ / shares shares	Mar. 10, 2016 shares	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Aug. 11, 2016 shares
Fair Value Adjustment of Options						$ 2,613
Gain (Loss) on Contract Modification						(2,126)
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions \| $ / shares	$ 0.15	$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions \| $ / shares	$ 0.25	$ 0.25
Common Stock Purchase Agreement, Remaining Number of Shares Required to be Purchased before Forfeiture of RIghts \| shares							300,000,000
Gain (Loss) on Contract Modification						(2,126)
Stock Issued During Period, Shares, New Issues \| shares	300,000,000		105,000,000
The 2016 Purchase Agreement [Member] \| The 200 Million Share, Call Option [Member]
Original Valuation, Options		$ 489
Derivative Liability, Current		2,931
The 2016 Purchase Agreement [Member] \| The 100 Million Share, Call Option [Member]
Original Valuation, Options		22
Derivative Liability, Current		$ 193
The 2016 Purchase Agreement [Member] \| Call Option [Member]
Fair Value Adjustment of Options						$ 2,613
The 2016 Purchase Agreement [Member] \| Call Option [Member] \| Measurement Input, Expected Term [Member]
Derivative Liability, Measurement Input		0.25
The 2016 Purchase Agreement [Member] \| Call Option [Member] \| Measurement Input, Option Volatility [Member]
Derivative Liability, Measurement Input		0.85
The 2016 Purchase Agreement [Member] \| Call Option [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Derivative Liability, Measurement Input		0.0031
The 2016 Purchase Agreement [Member] \| Call Option [Member] \| Measurement Input, Expected Dividend Rate [Member]
Derivative Liability, Measurement Input		0
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.15 [Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions \| shares	200,000,000	200,000,000
Stock Issued During Period, Shares, New Issues \| shares	200,000,000
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.25 [ Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions \| shares	100,000,000	100,000,000
Stock Issued During Period, Shares, New Issues \| shares	100,000,000

Note 14 - Shareholders' Equity (Details Textual) - USD ($)			1 Months Ended	12 Months Ended
	Oct. 26, 2016	Mar. 10, 2016	Nov. 30, 2016	Dec. 31, 2016	Dec. 31, 2018	Dec. 31, 2017	May 19, 2016	May 18, 2016	Jul. 15, 2015
Stock Issued During Period, Value, New Issues				$ 61,379,000
Common Stock, Shares Authorized					1,100,000,000	1,100,000,000	1,100,000,000	700,000,000
Warrants and Rights Outstanding					$ 18,179,000	$ 18,179,000
Warrants in Connection with Series A Preferred Stock Issuance [Member]
Warrants and Rights Outstanding									$ 18,179,000
Warrants in Connection with Series A Preferred Stock Issuance [Member] \| Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.48
Warrants in Connection with Series A Preferred Stock Issuance [Member] \| Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.49
Series A Preferred Stock [Member] \| Warrants in Connection with Series A Preferred Stock Issuance [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights									29,779,557
Investor Identification Agreement [Member]
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs			$ 750,000
The 2016 Purchase Plan [Member]
Stock Issued During Period, Shares, New Issues		105,000,000
Sale of Stock, Price Per Share		$ 0.08
Stock Issued During Period, Value, New Issues		$ 8,400,000
The 2016 Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues	300,000,000	105,000,000
Sale of Stock, Price Per Share		$ 0.08
Stock Issued During Period, Value, New Issues	$ 55,000,000	$ 8,400,000
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.15 [Member]
Stock Issued During Period, Shares, New Issues	200,000,000
Sale of Stock, Price Per Share	$ 0.15
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.25 [ Member]
Stock Issued During Period, Shares, New Issues	100,000,000
Sale of Stock, Price Per Share	$ 0.25

Note 15 - Stock Compensation Plan (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 27, 2015	Apr. 04, 2002
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	28,831,170	34,434,994	47,582,402
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	9,127,175	4,899,393
Allocated Share-based Compensation Expense, Total	$ 924	$ 1,255	$ 1,694
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total	$ 1,278	$ 1,665	$ 2,639
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rates Minimum	23.43%	19.86%	8.83%
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance	$ 0.14	$ 0.15
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost	$ 66	$ 261	$ 367
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	169,000
Equity Incentive Plan 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	11,755,503
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,217,175
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				40,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	16,906,667
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	7,910,000

Note 15 - Stock Compensation Plan - Assumptions Used to Estimate Fair Value (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Expected dividends
Minimum [Member]
Expected volatility	64.92%	45.20%	56.48%
Expected term (Year)	182 days	44 days	1 year
Risk-free rate	2.07%	0.82%	0.76%
Maximum [Member]
Expected volatility	99.30%	107.54%	115.39%
Expected term (Year)	6 years 73 days	5 years 310 days	6 years 116 days
Risk-free rate	2.97%	2.06%	2.13%

Note 15 - Stock Compensation Plan - Summary of Stock Option Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Options outstanding, number of shares (in shares)	34,434,994	47,582,402
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.17	$ 0.15
Granted, number of shares (in shares)	9,127,175	4,899,393
Granted, weighted average exercise price (in dollars per share)	$ 0.17	$ 0.20
Exercised, number of shares (in shares)	(5,438,716)	(10,978,664)
Exercised, weighted average exercise price (in dollars per share)	$ 0.09	$ 0.11
Forfeited, number of shares (in shares)	(8,479,583)	(7,052,137)
Forfeited, weighted average exercise price (in dollars per share)	$ 0.21	$ 0.15
Expired, number of shares (in shares)	(812,700)	(16,000)
Expired, weighted average exercise price (in dollars per share)	$ 0.29	$ 0.77
Options outstanding, number of shares (in shares)	28,831,170	34,434,994
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.17	$ 0.17
Options outstanding, contractual term (Year)	7 years 73 days
Options outstanding, aggregate intrinsic value	$ 241
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	15,212,177
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.18
Options exercisable, contractual term (Year)	5 years 292 days
Options exercisable, aggregate intrinsic value	$ 177
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance	13,618,993
Options unvested, weighted average exercise price (in dollars per share)	$ 0.17
Options unvested, contractual term (Year)	8 years 292 days
Options unvested, aggregate intrinsic value	$ 64
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	25,279,870
Options vested or expected to vest, weighted average exercise price (in dollars per share)	$ 0.17
Options vested or expected to vest, contractual term (Year)	6 years 328 days
Options vested or expected, aggregate intrinsic value	$ 235

Note 15 - Stock Compensation Plan - Supplemental Stock Option Information (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Weighted average grant date fair value per option granted (in dollars per share)	$ 0.13	$ 0.18	$ 0.08
Fair value of options vested	$ 911	$ 1,192	$ 2,022
Proceeds from exercise of stock options	463	1,238	206
Intrinsic value of options exercised	$ 537	$ 2,271	$ 221

Note 15 - Stock Compensation Plan - Summary of Stock Options Outstanding and Exercisable by Ranges of Option Prices (Details)	12 Months Ended
	Dec. 31, 2018 $ / shares shares
Number of options outstanding (in shares) \| shares	28,831,170
Number of options exercisable (in shares) \| shares	15,212,177
Exercise Price Range 1 [Member]
Range of exercise prices, lower (in dollars per share)	$ 0
Range of exercise prices, upper (in dollars per share)	$ 0.10
Number of options outstanding (in shares) \| shares	6,897,943
Options outstanding, weighted average remaining contractual life (Year)	5 years 332 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.08
Number of options exercisable (in shares) \| shares	5,165,194
Options exercisable, weighted average remaining contractual life (Year)	5 years 193 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.08
Exercise Price Range 2 [Member]
Range of exercise prices, lower (in dollars per share)	0.11
Range of exercise prices, upper (in dollars per share)	$ 0.38
Number of options outstanding (in shares) \| shares	21,933,227
Options outstanding, weighted average remaining contractual life (Year)	7 years 233 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.20
Number of options exercisable (in shares) \| shares	10,046,983
Options exercisable, weighted average remaining contractual life (Year)	5 years 317 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.23

Note 16 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
Note 16 - Income Taxes (Details Textual) - USD ($)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 5,553,000	$ 18,383,000
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	34.00%	34.00%
Deferred Tax Asset, Increase (Decrease) from Remeasurement Due to Tax Rate Change	$ (20,531,000)
Deferred Tax Assets, Valuation Allowance, Increase (Decrease) from Remeasurement Due to Tax Rate Change	(20,531,000)
Adjustments to Additional Paid in Capital, Share-based Compensation and Exercise of Stock Options	325,000
Net Operating Loss Carryforward Limitation	764,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total	0	$ 0	$ 0
Employee Stock Option [Member]
Unrecognized Tax Benefits, Ending Balance	325,000
Domestic Tax Authority [Member]
Operating Loss Carryforwards, Total	130,700,000
Domestic Tax Authority [Member] \| Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	138,000
Domestic Tax Authority [Member] \| Liquidmetal Golf, Inc [Member]
Operating Loss Carryforwards, Total	$ 36,200,000
Domestic Tax Authority [Member] \| Internal Revenue Service (IRS) [Member]
Open Tax Year	2014 2015 2016 2017 2018
State and Local Jurisdiction [Member] \| California Franchise Tax Board [Member]
Operating Loss Carryforwards, Total	$ 90,000,000
Open Tax Year	2013 2014 2015 2016 2017 2018
State and Local Jurisdiction [Member] \| California Franchise Tax Board [Member] \| Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	$ 243,000

Note 16 - Income Taxes - Significant Components of Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Loss carry forwards	$ 33,733	$ 39,304
Derivative valuations	259	521
NQSO	1,964	1,794
Tax Credits	331	382
Other	107	(54)
Total deferred tax asset	36,394	41,947
Valuation allowance	(36,394)	(41,947)
Total deferred tax asset, net

Note 16 - Income Taxes - Differences Between the Expected Federal Tax Benefit and Actual Tax Provision (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Expected federal tax benefit	(21.00%)	(34.00%)	(34.00%)
Permanent items	0.90%	1.70%	5.60%
Net operating loss utilized or expired	0.00%	0.00%	0.00%
Increase in valuation allowance and others	20.10%	32.30%	28.40%
Effective tax rate	0.00%	0.00%	0.00%

Note 17 - Loss Per Common Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$ 0.17	$ 0.17	$ 0.15
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	28,831,170	34,434,994	47,582,402
Employee Stock Option [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$ 0.07	$ 0.07	$ 0.07
Employee Stock Option [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$ 0.38	$ 0.47	$ 0.77
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	10,066,809	10,066,809	41,924,653
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.07	$ 0.07
Warrant [Member] \| Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.07
Warrant [Member] \| Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.17

Note 21 - Related Party Transactions (Details Textual) - USD ($)			12 Months Ended
	Aug. 16, 2017	Nov. 17, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Mar. 10, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number			25,279,870
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance			13,618,993
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number			15,212,177
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost			$ 66,000	$ 261,000	$ 367,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors						405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors						$ 63,400,000
Mr. Steipp [Member] \| The Separation Agreement [Member]
Severance Costs		$ 300,000
Separation Agreement, Period for COBRA Healthcare Coverage		1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number		3,990,400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance		9,939,451
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		10,777,949
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost					297,000
Accrued Liabilities, Total			0	0
Former CFO [Member] \| Former CFO Separation Agreement [Member]
Separation Agreement, Period for COBRA Healthcare Coverage	1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	247,650
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	2,889,749
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost			48,000	89,000
Accrued Liabilities, Total			$ 0	164,000
Separation Agreement, Base Annual Salary	$ 240,000
Separation Agreement, Period for Base Annual Salary	1 year
Chairman of Eontec [Member] \| Minimum [Member]
Beneficial Ownership Percentage			5.00%
Eontec [Member] \| License Agreement [Member]
Related Party Transaction, Amounts of Transaction			$ 213,000	$ 877,000	$ 68,000

Note 22 - Quarterly Financial Information (Unaudited) - Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenue	$ 144	$ 253	$ 55	$ 80	$ 179	$ 36	$ 58	$ 48	$ 532	$ 321
Gross profit (loss)	6	(631)	(6)	(1)	(301)	(51)	(9)	(14)	(632)	(375)	$ (73)
Operating loss	(1,974)	(2,613)	(2,177)	(2,196)	(2,406)	(2,290)	(1,797)	(2,109)	(8,960)	(8,602)	(9,887)
Net loss and comprehensive loss	$ (1,198)	$ (1,939)	$ (1,859)	$ (2,438)	$ 27	$ (3,951)	$ (3,821)	$ (945)	$ (7,434)	$ (8,690)	$ (18,752)
Basic and diluted net loss per common share (in dollars per share)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (0.01)	$ (0.01)

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686

+ Details

Schedule II - Valuation and Qualifying Accounts - Summary of Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Balance at beginning of period	$ 41,947	$ 60,330	$ 55,079
Charged to costs and expenses	1,980	2,834	6,675
Charged to other accounts	0	0	0
Deductions	(7,533)	(21,217)	(1,424)
Balance at end of period	36,394	41,947	60,330
SEC Schedule, 12-09, Allowance, Credit Loss [Member]
Balance at beginning of period
Charged to costs and expenses
Charged to other accounts
Deductions
Balance at end of period
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]
Balance at beginning of period	41,947	60,330	55,079
Charged to costs and expenses	1,980	2,834	6,675
Charged to other accounts
Deductions	(7,533)	(21,217)	(1,424)
Balance at end of period	$ 36,394	$ 41,947	$ 60,330

Note 9 - Short-term Debt	12 Months Ended
Note 9 - Short-term Debt	Dec. 31, 2018
Notes to Financial Statements
Short-term Debt [Text Block]	9 . Short-Term Debt Short-term debt totaled $0 and $0 as of December 31, 2018 and December 31, 2017, respectively, and consisted of borrowings under a line of credit facility, with a fixed interest rate of 2.1%. All borrowings were fully repaid upon maturity of the facility on August 26, 2016. Interest expense related to outstanding borrowings was $0, $0, and $9 for the years ended December 31, 2018, 2017, and 2016, respectively. This credit facility required the Company to maintain collateral for the full amount of the facility. Upon maturity of the facility all collateral requirements were removed.

Note 13 - Other Long-term Liabilities	12 Months Ended
Note 13 - Other Long-term Liabilities	Dec. 31, 2018
Notes to Financial Statements
Other Liabilities Disclosure [Text Block]	1 3 . Other Long-Term Liabilities Other Long-term liabilities balance of $856 and $856 as of December 31, 2018 and 2017, respectively, consists of long term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or write-off in accordance with applicable accounting rules.

Note 18 - Segment Information	12 Months Ended
Note 18 - Segment Information	Dec. 31, 2018
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	1 8 . Segment Information The primary business of the Company is to develop and manufacture products and applications from amorphous alloys. As a result, the Company’s financial results are reported in a single segment.

Note 19 - Commitments and Contingencies	12 Months Ended
Note 19 - Commitments and Contingencies	Dec. 31, 2018
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	19 . Commitments and Contingencies Capital Commitments As of December 31, 2018 the Company had executed contracts, with remaining minimum commitments of $253, for capital expenditures related to upgrading the power supply for the Company’s manufacturing facility. Such upgrades are expected to be completed during the first half of 2019. Legal Contingencies In addition to the matters disclosed in these footnotes, the Company is involved in other legal proceedings regarding matters arising in the normal course of business. The Company believes the outcome of these other proceedings will not, individually or in the aggregate, materially affect its consolidated financial position, results of operations and cash flows.

Note 20 - 401(k) Savings Plan	12 Months Ended
Note 20 - 401(k) Savings Plan	Dec. 31, 2018
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	20 . 401 (k) Savings Plan The Company has a tax-qualified employee savings and retirement plan, or 401 (k) plan. Under the 401 (k) plan, participants may elect to reduce their current compensation, on a pre-tax basis, by up to 15% of their taxable compensation or of the statutorily prescribed annual limit, whichever is lower, and have the amount of the reduction contributed to the 401 (k) plan. The 401 (k) plan permits the Company, in its sole discretion, to make additional employer contributions to the 401 (k) plan. However, the Company did not make employer contributions to the 401 (k) plan during any of the periods presented in the accompanying consolidated financial statements.

Note 8 - Patents and Trademarks, Net - Accumulated Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accumulated amortization	$ (2,078)	$ (1,992)
Purchased and Licensed Patent Rights [Member]
Accumulated amortization	(548)	(541)
Internally Developed Patents [Member]
Accumulated amortization	(1,400)	(1,326)
Trademarks [Member]
Accumulated amortization	$ (130)	$ (125)

Note 11 - Warrant Liabilities - Outstanding Warrants to Acquire Shares of the Common Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Number of shares (in shares)	10,066,809	41,924,653
Warrant 1 [Member]
Number of shares (in shares)	10,066,809
Exercise price (in dollars per share)	$ 0.07
Expiration date	Mar. 10, 2026

Note 13 - Other Long-term Liabilities (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Other Liabilities, Noncurrent, Total	$ 856	$ 856
Period for Outstanding Liability	5 years

Note 19 - Commitments and Contingencies (Details Textual) $ in Thousands	Dec. 31, 2018 USD ($)
Commitments for Capital Expenditures Related to Power Supply Upgrade [Member]
Purchase Commitment, Remaining Minimum Amount Committed	$ 253